Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of intravenous vancomycin on renal function.

R H Eng1, L Wynn, S M Smith

  • 1Infectious Disease Section, Veterans Administration Medical Center, East Orange, N.J.

Chemotherapy
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters.

Frontiers in immunology·2026
Same author

Role of CD8 T cells in mycobacterial infections.

Immunology and cell biology·2000
Same author

Food and nutrition in space: application to human health.

Nutrition (Burbank, Los Angeles County, Calif.)·2000
Same author

A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.

Molecular cell biology research communications : MCBRC·2000
Same author

Category structure and created memories.

Memory & cognition·2000
Same author

Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population.

The Annals of pharmacotherapy·2000

Intravenous vancomycin administration showed minimal impact on renal function in a study of 23 patients. Clinically significant nephrotoxicity was observed in 17%, potentially linked to underlying infections rather than the antibiotic itself.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Vancomycin, an antibiotic, has historically been associated with nephrotoxicity.
  • Recent advancements in vancomycin purity have led to questions about its renal toxicity.
  • Understanding the current risk of vancomycin-induced kidney damage is crucial for patient care.

Purpose of the Study:

  • To prospectively evaluate the incidence of renal function changes during intravenous vancomycin therapy.
  • To determine if modern vancomycin preparations retain nephrotoxic potential.
  • To assess the relationship between vancomycin administration and changes in renal biomarkers.

Main Methods:

  • Prospective examination of 23 patients receiving intravenous vancomycin.
  • Monitoring of blood urea nitrogen (BUN) and serum creatinine levels.

Related Experiment Videos

  • Average vancomycin administration duration of 15 days.

    • Main Results:

    • Average BUN change was +1.7 mg/dl; average creatinine change was +0.06 mg/dl.
    • Clinically significant renal function deterioration occurred in 4 patients (17%).
    • Worsening renal function in affected patients was suspected to be related to the treated infection.

    Conclusions:

    • The nephrotoxicity of intravenous vancomycin may be lower than previously believed with current preparations.
    • Close monitoring of vancomycin dosing is essential.
    • Infection severity may be a confounding factor in observed renal function changes.